Amoebiasis : Information

Introduction : Amoebiasis

Amoebiasis

Amoebiasis is a disease caused by the parasiteEntamoeba histolytica. Only about 10% to 20% of people who are infected withE. histolyticabecome sick from the infection. It can affect anyone, although it is more common in people who live in tropical areas with poor sanitary conditions.

Amoebiasis is a common infection of the human gastro-intestinal tract. Amoebiasis is more closely related to poor sanitation and socioeconomic status than to climate. It has worldwide distribution. It is a major health problem in China, South East and West Asia and Latin America, especially Mexico.

Amoebiasis affects about 15% of Indian population. It has been reported throughout India.

In addition to being a potentially lethal disease, invasive amoebiasis has important social and economic consequences. Temporarily incapacitating infections, which are frequent in adult males in the wage-earning age group, may require several weeks of hospitalization and 2-3 months for full recovery. Amoebiasis may cause clinical problems in persons with immunodeficiency, homosexuals and immigrants from certain tropical countries, and travellers.


References:

  • http://www.cdc.gov
  • www.ncbi.nlm.nih.gov

Parks Textbook of Preventive and Social Medicine, 22nd Edition, Amoebiasis, 219-220

Symptoms : Amoebiasis

The clinical spectrum ranges from asymptomatic infection, diarrhoea and dysentery to fulminant colitis and peritonitis as well as extra-intestinal amoebiasis.

Acute amoebiasis can present as diarrhoea or dysentery with frequent, small and often bloody stools.

Chronic amoebiasis can present with gastrointestinal symptoms plus fatigue, weight loss and occasional fever.

Extra-intestinal amoebiasis can occur if the parasite spreads to other organs, most commonly the liver where it causes amoebic liver abscess. Amoebic liver abscess presents with fever and right upper quadrant abdominal pain.

Other organs can also be involved, including pleuropulmonary, cardiac, cerebral, renal, genitourinary, peritoneal, and cutaneous sites. In developed countries, amebiasis primarily affects migrants from and travellers to endemic regions, men who have sex with men, and immunosuppressed or institutionalized individuals.

Reference

  • www.cdc.gov]
Causes : Amoebiasis

Amoebiasis is caused by parasite Entamoeba histolytica. Several protozoan species in the genus Entamoeba colonize humans, but not all of them are associated with disease. It exists in two forms- Vegetative (trophozoite) and cystic forms (cyst). Trophozoites multiply and encyst in the colon. The cysts are excreted in stool and are infective to humans. Cysts remain viable and infective for several days in faeces, water, sewage and soil in the presence of moisture and low temperature.

Transmission occurs via:

  • Faecal oral route, either directly by person-to-person contact or indirectly by eating or drinking faecally contaminated food or water.
  • Sexual transmission by oral-rectal contact is also recognized especially among male homosexuals.
  • Vectors such as flies, cockroaches and rodents can also transmit the infection.

The incubation period for E histolytica infection is commonly 2-4 weeks but may range from a few days to years.

The use of night soil for agricultural purposes favours the spread of the disease. Epidemic/ outbreaks (occurrence of more cases of a disease than would be expected in a community or region during a given time period) are usually associated with sewage seepage into the water supply.

References
  • www.who.int

Park s Textbook of Preventive and Social Medicine, 22 nd Edition, Amoebiasis, 219-220

Diagnosis : Amoebiasis

Entamoeba histolytica must be differentiated from other intestinal protozoa. Microscopic identification of cysts and trophozoites in the stool is the common method for diagnosing E. histolytica. Differentiation is based on morphologic characteristics of the cysts and trophozoites. In addition, E. histolytica trophozoites can also be identified in aspirates or biopsy samples obtained during colonoscopy or surgery.

Immunodiagnosis - Antibody Detection-

a) Enzyme immunoassay (EIA) is most useful in patients with extra-intestinal disease (i.e., amoebic liver abscess) when organisms are not generally found on stool examination.

b) Indirect hemagglutination (IHA).

If antibodies are not detectable in patients with an acute presentation of suspected amoebic liver abscess, a second specimen should be drawn 7-10 days later. If the second specimen does not show sero-conversion, other tests should be considered. Detectable E. histolytica-specific antibodies may persist for years after successful treatment, so the presence of antibodies does not necessarily indicate acute or current infection.

Antigen Detection-

Antigen detection may be useful as an adjunct to microscopic diagnosis in detecting parasites and to distinguish between pathogenic and nonpathogenic infections.

Molecular Diagnosis-

Conventional Polymerase chain reaction (PCR)-In reference diagnosis laboratories, molecular analysis by PCR-based assays is the method of choice for discriminating between the pathogenic species (E. histolytica) and the nonpathogenic species (E. dispar). Radiography, Ultrasonography, Computed tomography (CT) and Magnetic resonance imaging (MRI) can be used for detection of liver abscess, cerebral amoebiasis. Rectosigmoidoscopy and colonoscopy can provide diagnostic information in intestinal amoebiasis.


References:

www.cdc.gov
emedicine.medscape.com

Management : Amoebiasis

For symptomatic intestinal infection and extra intestinal disease, treatment with antiamoebic drugs should be taken with consultation of a physician. Asymptomatic patients infected with E. histolytica should also be treated with antiamoebic drugs, because they can infect others and because 4% 10% develop disease within a year if left untreated.

Liver aspiration- Liver aspiration is indicated only if abscesses are large (> 12 cm), abscess rupture is imminent, medical therapy has failed, or abscesses are present in the left lobe.


References:

  • wwwnc.cdc.gov
  • emedicine.medscape.com]
Prevention : Amoebiasis

Amoebiasis can be prevented and controlled both by non-specific and specific measures.

Non-specific measures are concerned with-

Improved water supply- The cysts are not killed by chlorine in amount used for water disinfection. Water filtration and boiling are more effective than chemical treatment of water against amoebiasis. Sanitation-Safe disposal of human excreta coupled with the sanitary practice of washing hands after defecation and always before handling and consuming food. Food safety- Uncooked fruits and vegetables should be washed thoroughly with safe water, peel fruits, and boil vegetables prior to eating.Measures should also include the protection of food and drink from flies and cockroaches and the control of these insects. Carriers, who pass cysts and are involved in handling food, whether at home, at street stalls, or in catering establishments, should be actively detected and treated since they are major transmitters of amoebiasis. Health education of the public as well as health personnel at all levels about sanitation and food hygiene-Elementary hygienic practices should be propagated and constantly reinforced in schools, health care units, and the home through periodic campaigns using the mass media. General social and economic development-The implementation of individual and community preventive measures (e.g., washing of hands, proper excreta disposal) should be an essential part of these activities.

Specific measures that should be undertaken when possible are-

community surveys to monitor the local epidemiological situation with regard to amoebiasis; improvement of case management, i.e., rapid diagnosis and adequate treatment of patients with invasive amoebiasis at all levels of the health services, including the community and health centre levels; surveillance and control of situations that may encourage the further spread of amoebiasis, e.g., refugee camps, contaminated public water sources.


References:

  • www.ncbi.nlm.nih.gov
  • www.who.int]
Medical Condition : Amoebiasis : Digestive